Orlando, Florida, June 26, 2010 (ots/PRNewswire) – Results from a 24-week Phase 3 clinical study demonstrated that the addition of the investigational drug dapagliflozin achieved reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients who were treated with insulin (with or without oral anti-diabetes medications (OADs)), compared to [...]
Tag Archive > Insulin Dose
Gerresheimer sets up new production facility for insulin pen systems in Brazil
Düsseldorf (ots) – * Expansion of cooperation with diabetes leader Novo Nordisk * Important step in the worldwide development of medical plastic systems The Gerresheimer Group has set up a new facility for medical plastic systems in Indaiatuba (Brazil). The plant is to commence operations early in 2010. On the basis of a long-term cooperation [...]
